Use of Oxandrolone to Promote Growth in Infants With HLHS
Status:
Active, not recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
The primary aim of this study is to determine if clinically relevant doses of buccally
administered oxandrolone are safe and tolerable in neonates with hypoplastic left heart
syndrome (HLHS) or other single right ventricular anomalies who have undergone a Norwood
procedure. The secondary aim is to evaluate the efficacy of buccally administered oxandrolone
in improving objective indices of growth and nutrition in neonates who have undergone a
Norwood procedure.